Search clinical trials for: Nebulized Budesonide

Total 787 results

Gilead Sciences

Completed

Safety and Efficacy of SOF/VEL/VOX FDC for 8 Weeks and SOF/VEL for 12 Weeks in Adults Chronic Genotype 3 HCV Infection and Cirrhosis (POLARIS-3)

Hepatitis C Virus Infection

United States, France, United Kingdom, Germany, Australia, Canada, New Zealand, Puerto Rico
AstraZeneca
Parexel

Completed

A Study to Assess How Much Drug Reaches the Blood When Given From Symbicort pMDI With Spacer Compared to That of Symbicort pMDI Without Spacer in Healthy Volunteers

Study is Being Conducted in Healthy Volunteers

United Kingdom
AstraZeneca
Parexel

Completed

Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, and Formoterol Delivered by BGF MDI HFO Compared With BGF MDI HFA

Chronic Obstructive Pulmonary Disease

United States
AstraZeneca

Completed

Efficacy and Tolerability Study in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients (SECURE2)

Chronic Obstructive Pulmonary Disease (COPD)

China
R3 Stem Cell

Not yet recruiting

Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions

Stroke | Autoimmune Diseases | Kidney Diseases | Urologic Diseases | Renal Insufficiency | Arthritis | Renal Failure | Alzheimer Disease | Erectile Dysfunction | Cardiomyopathies | Pulmonary Disease | Neurologic Disorder | Orthopedic Disorder | COPD | Cardiac Event | CHF | Neuropathy;Peripheral
Dr. Aayush Khanal, MD

Completed

Efficacy of Nebulised Hypertonic Saline (3%) Among Children With Bronchiolitis.

Bronchiolitis

Nepal
Cliniques universitaires Saint-Luc- Université...

Completed

Dosimetry and Safety Phase 1 Study With 68Ga-PSMA-11 Sterile Cold Kit (PSMA)

Prostatic Neoplasm

Belgium
Guangzhou Institute of Respiratory Disease

Unknown

Efficacy and Safety of Hydrogen Inhalation on Bronchiectasis: A Randomized, Multi-center, Double-blind Study (HYBRID)

Bronchiectasis | Oxidative Stress | Acute Exacerbation of Bronchiectasis

China
Elpen Pharmaceutical Co. Inc.

Completed

Evaluation of the Effectiveness and Quality of Life With the Administration of the Fixed Combination of Budesonide Formoterol in Greek Patients With Asthma During Routine Clinical Practice. (BOREAS)

Quality of Life | Asthma

Greece
Boston Children's Hospital
Brigham and Women's Hospital

Terminated

Trial on the Effect of Budesonide/Formoterol and Inhaled Budesonide Alone on Exercise-Induced Asthma

Exercise Induced Asthma

United States
Beijing Tongren Hospital

Completed

Compare the Effect of INS Alone and Added LTRA in Treatment of SAR

Allergic Rhinitis

China
Romaker & Associates
Merck Sharp & Dohme LLC

Completed

Montelukast and Inhaled Nasal Steroid Tx in Adult Obstructive Sleep Apnea (OSA)

Obstructive Sleep Apnea

United States
Elpen Pharmaceutical Co. Inc.

Completed

Quality of Life Assessment in Greek asthmatIc Patients Treated With the Fixed Dose Combination of Budesonide / Formoterol in Clinical Practice (SKIRON)

Quality of Life | Asthma | Satisfaction

Greece
Postgraduate Institute of Medical Education and...

Completed

A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary Aspergillosis

Allergic Bronchopulmonary Aspergillosis

India
Temple University

Unknown

Effect of Symbicort on Sleep Quality in Patients With Emphysema

Emphysema | Poor Sleep Quality

United States
Assistance Publique - Hôpitaux de Paris

Completed

Inhaled BUDESONIDE/FORMOTEROL in Bronchiolitis Obliterans Following Stem Cell Transplantation (alloforb)

Bronchiolitis Obliterans | Allogeneic Stem Cell Transplantation

France
AstraZeneca

Completed

Symbicort Single Inhaler Therapy for Asthma in a General Practice Setting

Asthma

Netherlands
AstraZeneca

Completed

Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma

Asthma

Japan
AstraZeneca

Completed

Local Phase 4 Pan-European SMART Study

Asthma

Italy, Sweden, France, Russian Federation, Spain, United Kingdom, Germany, Finland, Norway, Belgium, Netherlands, Greece, Ireland, Iceland
AstraZeneca

Completed

A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD

Chronic Obstructive Pulmonary Disease

United States, Bulgaria, Germany, Hungary, Romania, Denmark, Greece, Mexico, Iceland
Bayer

Completed

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Melanoma

Melanoma
AstraZeneca

Completed

A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate

Pulmonary Disease, Chronic Obstructive

United Kingdom
University of Maryland, Baltimore
Milton S. Hershey Medical Center; Vanderbilt University; Mercy Medical Center

Completed

Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease

Crohn's Disease | IBD

United States
Teva Pharma GmbH

Completed

Study to Evaluate Satisfaction and Usability of DuoResp® SPIROMAX® in Asthma and COPD Treatment

Patient Satisfaction

Germany
AstraZeneca

Completed

Evaluation of an Oxygen Enhanced Magnetic Resonance Imaging Method on Patients With Chronic Obstructive Pulmonary Disease During 8 Weeks Treatment With Either Symbicort Turbuhaler or Oxis Turbuhaler

COPD Method Evaluation | Chronic Obstructive Pulmonary Disease Method Evaluation

United Kingdom, Sweden
Gelb, Arthur F., M.D.

Recruiting

Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

Asthma

United States
Ataturk University

Not yet recruiting

Comparison of Bronchodilator Treatment Practices in Group E COPD Patients

COPD Exacerbation Acute
Chiesi Farmaceutici S.p.A.

Completed

Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®)

Bronchial Asthma

Austria, Poland, Ukraine
Oman Medical Speciality Board

Not yet recruiting

Nebulized Salbutamol in Acute Renal Colic

Renal Colic
Fraunhofer-Institute of Toxicology and Experimental...

Completed

Suitability of a Low Dose Lipopolysaccharide (LPS) Inhalation as a Challenge Model

Healthy

Germany
Zambon SpA
FLUIDDA nv

Completed

Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic Patients

Asthma | Asthma Chronic | Asthmatic | Asthma Bronchial

Belgium
Xian-Janssen Pharmaceutical Ltd.

Completed

Efficacy and Safety of Prucalopride in Combination With Polyethylene Glycol or Lactulose in Women With Chronic Constipation

Constipation

China
ALK-Abelló A/S

Completed

Efficacy of SLITone in House Dust Mite Allergic Patients

Allergy

Spain
Zhujiang Hospital

Unknown

Differences of Small Airways Function Between Chronic Obstructive Pulmonary Disease(COPD) and Asthma-copd Overlap(ACO)

Quality of Life | Pulmonary Disease, Chronic Obstructive | Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome | Small Airway Disease

China
Zhujiang Hospital

Unknown

Change of Lung Function After Exercise in Patients With Chronic Obstructive Pulmonary Disease

Quality of Life | Pulmonary Disease, Chronic Obstructive | Exercise | Lung Function Decreased

China
Zhujiang Hospital

Unknown

Small Airways Evaluation and Treatment

Pulmonary Disease，Chronic Obstructive;

China
Intech Biopharm Ltd.

Completed

Multiple-dose Pharmacokinetics Study of "SYN006 HFA MDI" Administered Orally to Healthy Volunteers

Asthma

Taiwan
AstraZeneca

Completed

Pulmicort Respules(Budesonide Inhalation Suspension) vs Singulair, Children

Asthma
Second Affiliated Hospital, School of Medicine,...

Not yet recruiting

Factors Influencing the Prognosis of Olfactory Dysfunction After Upper Sensation

Outcome

China
Lawson Health Research Institute

Withdrawn

Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19)

Olfactory Disorder

Canada
GlaxoSmithKline

Completed

Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects

Asthma

United Kingdom, Germany
Huashan Hospital

Unknown

Efficiency of Budesonide Combined With Formoterol and Tiotropium in the Treatment of Acute Exacerbation of ACO

Asthma-COPD Overlap
University of Arizona

Recruiting

Intra-tracheal Instillation of Budesonide to Prevent Chronic Lung Disease (STOPCLD)

Acute Lung Injury | Chronic Lung Disease of Prematurity | Infant, Extremely Premature | Budesonide

United States
GlaxoSmithKline

Completed

CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca.

Asthma

Canada, Bulgaria, Estonia, Spain, Netherlands, Germany, Australia, Austria, Belgium, Finland, Ireland, Latvia, Macedonia, The Former Yugoslav Republic of, New Zealand, United Kingdom
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers (Reco-Pilot)

Asthma

Finland
AstraZeneca

Completed

Comparison Between Symbicort® and Prednisolone in COPD (SPACE)

Chronic Obstructive Pulmonary Disease

Sweden, Germany, Norway, Denmark, Finland
Hospital General Naval de Alta Especialidad - Escuela...

Unknown

Nebulized Magnesium Sulfate as an Adjunct to Standard Therapy in Asthma Exacerbation

Asthma

Mexico
Air Force Military Medical University, China

Unknown

Study of Bosentan in the Treatment of Stable Severe Chronic Obstructive Pulmonary Disease Patients (BTCOPD)

Chronic Obstructive Pulmonary Disease (COPD)

China
Virginia Polytechnic Institute and State University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Angiotensin II Blockade and Inflammation in Obesity (ARB)

Hypertension | Overweight | Prehypertension | Obese
Research in Real-Life Ltd
Mundipharma Research Limited

Completed

Real-world Effectiveness of Combination Therapy in Asthma

Asthma

United Kingdom

3

Subscribe